Low-dose ionising radiation may affect living cells in three ways: 1) injured or damaged cells repair themselves without residual damage; 2) cells die; or 3) cells misrepair themselves, which eventually lead to a structural and/or functional change.
Radiation-induced aberrations can be observed in human lymphocytes within a few hours from exposure; their frequency is related to the dose and type of radiation, and can be detected in blood samples taken long after the exposure (1) . Chromosomal damage can indirectly be estimated by scoring micronuclei (MN) (2) . The formation of MN in dividing cells is the result of unrepaired or misrepaired chromosomal breaks or chromosome malsegregation due to mitotic malfunction (3) . Most MN studies have been using cultured peripheral lymphocytes, which lend themselves well to both genotoxicity testing and biomonitoring.
This study focused on chronic occupational exposure to ionising radiation. Earlier investigation has shown that 3 % of radiologists occupationally exposed to ionising radiation carry dicentric chromosomes in their lymphocytes. Most of them showed a signifi cantly decreased leukocyte ability to undergo apoptosis (4) . Two factors blur the association between radiation exposure and clinical effects, that is, individual variability (due to genetic and environmental factors) and the presence of various defensive mechanisms which counteract to oxidative stress induced by irradiation (5) . Current biomonitoring mostly uses cytogenetic markers of chromosomal aberrations and micronuclei in circulating lymphocytes. These biomarkers may be useful to identify individuals more vulnerable to radiation damage, and who might be eligible for preventive measures such as limiting the exposure and pharmacological or dietary radioprotection.
The aim of this study was to evaluate the radioprotective properties of Echinacea purpurea extracts in vivo. For this purpose, radiology technicians, who were identifi ed as carrying dicentrics in their lymphocytes were asked to take Echinacea purpurea tablets and were analysed for chromosome aberrations, micronuclei, apoptosis, and haematological parameters before and after the treatment.
MATERIALS AND METHODS

Study design
The exposed group included 10 radiology technicians identifi ed as carrying dicentric chromosomes in their lymphocytes during routine checkups. Lymphocyte aberrations in these subjects were accompanied by mild leucopoenia and imbalance in the ratio between lymphocytes, monocytes, and granulocytes. Ten subjects, all men, were willing to take two Echinacea purpurea tablets (Ehinacea ® , Strong Nature, Serbia) twice a day (b.i.d.) for two weeks. Each 275 mg tablet contains Echinacea purpurea dry extract standardised at 8.3 % of total phenolic content (calculated in terms of chlorogenic acid units). Echinacea preparation contains caffeic acid derivatives, sugar, and caffeic acid esters -echinacosides. Throughout the treatment, the 10 subject took no other drugs/preparations or vitamin supplements.
The average group age was (38.7±3.4) years, and average occupational exposure duration (14.6±3.4) years. The radiation doses measured by thermoluminescent dosimeters (TLD) on the chest were below the annual limit of 20 mSv (Table 1) . Lymphocyte micronuclei, chromosomal aberrations, and apoptosis were analyzed at the beginning and at the end of treatment. This study used each subject as his own control.
Blood sampling
Peripheral blood samples were collected in heparinised vacutainers by venipuncture in accordance with the Declaration of Helsinki and current health ethics regulations in Serbia (6, 7) . Venous blood was collected in a test tube containing an anticoagulant (ethylenediaminetetraacetic acid, EDTA) to prevent clotting.
Blood count
The blood was mixed well (but not shaken) and inserted into the haematology analyzer CELL-DYN 3700 (Abbott Laboratories, Illinois, USA) that recorded haemoglobin concentration, red blood cell (RBC), white blood cell (WBC), neutrophil (NpG), lymphocyte (Ly), and monocyte (Mo) counts.
Chromosomal aberration analysis
For scoring chromosomal aberrations, standard methods (1) were used: aliquots of heparinised whole blood (0.5 mL) were set up in cultures containing PBmax-karyotyping medium (Invitrogen-Gibco, Paisley, UK). Cells were harvested 48 h after initiation of culture. For the last three hours the cells were cultured in the presence of colchicine (Sigma Aldrich, St. Louis, MO. USA) in the fi nal concentration of 2.5 µg mL -1 . Slides were prepared according to the standard protocol for chromosomal aberration analysis. After staining, 200 well-spread and complete fi rst-division metaphases per subject were analysed for unstable chromosome-type aberrations, i.e. dicentric and rings chromosomes, and acentric fragments. The scoring criteria were based on the IAEA recommendations (1) .
Micronucleus test
For the micronucleus test, aliquots of heparinised whole blood (0.5 mL) were set up in cultures containing PBmax-karyotyping medium (InvitrogenGibco). The slides were prepared according to the method described by Fenech (8) . At least 1000 binucleated cells were scored per culture. Cytokinesisblock proliferation index (CBPI) was calculated using the following equation:
where MI-MIV is the number of cells with one to four nuclei, respectively, and N is the number of cells scored (9) .
Apoptosis of leukocytes
For the apoptosis assay, blood aliquots of 0.5 mL from each subject were incubated with the RPMI-1640 medium (Invitrogen-Gibco) supplemented with 15 % calf serum without phytohaemagglutininin in a CO 2 incubator for 24 h. After incubation, cells were gently washed with saline (0.9 % NaCl) at 37 °C and fi xed in methanol:acetic acid (3:1). The pellet was then fi xed in 96 % ethanol. Apoptosis was assessed by fl ow cytometric identifi cation of cells displaying apoptosisassociated DNA condensation. Three parameters were measured: cell size, granularity, and DNA content. DNA content was assessed by measuring the UV fluorescence of propidium iodide-stained DNA. Cytotoxicity was defi ned as the population of cells with reduced DNA fl uorescence (10) . Each analysis included 10000 events per sample.
Statistics
Statistical analysis of each parameter was carried out using the statistical software package Statistica version 5.5 for Windows. It included the frequency of chromosomal aberrations and micronuclei in binucleated cells, leukocyte count, and absolute lymphocyte, granulocyte (neutrophil), and monocyte counts. The results were evaluated using the Spearman rank order correlation and Wilcoxon matched-paired test. Table 2 and Figure 1a -c show individual data on haemoglobin concentration, red blood cell
RESULTS
Figure 1 Percentage of granulocytes (a), lymphocytes (b), monocytes (c), and apoptotic leukocytes (d) in radiology technicians before (open circle) and after a two-week treatment with Echinacea purpurea preparation (closed circle).
Granulocytes / % Monocytes / % Lymphoocytes / % Apoptotic leucocytes / % (RBC), white blood cell (WBC), neutrophil (NpG), lymphocyte (Ly), and monocyte (Mo) counts in radiology technicians. Apoptosis is expressed as the percentage of cells displaying apoptotic granularity (Figure 1d ). The sum of exchange aberrations, lymphocyte micronuclei, and proliferation index are shown on Table 3 .
At the beginning of treatment, the leukocyte count positively correlated with the incidence of chromosomal aberrations and negatively with At the end of the treatment, a statistically signifi cant correlation was found between the absolute granulocyte count and micronuclei (R=0.68, P<0.05). An inverse correlation at the border of signifi cance was found between the monocyte count and the percentage apoptotic leukocytes (R=-0.59, P<0.06).
Wilcoxon matched-pairs test showed statistically signifi cant differences in micronucleus frequency and apoptotic cells between the beginning and the end of the treatment (Z=1.99, P<0.05 and Z=2.49, P<0.02, respectively). We also found a statistically signifi cant difference between the percentage of monocytes at the beginning and at the end of the treatment (Z=2.09, P<0.04).
DISCUSSION
Echinacea tablets have been marketed in Serbia as a herbal remedy. Previous studies with Echinacea preparations suggest that these products, possess antioxidative properties thanks to high phenolic content (11, 12) . We based our dosage on earlier studies which used Echinacea at relatively low doses, lower than those used by many practicing herbalists (12) .
Our group of ten volunteers was rather homogenous in age and occupational exposure duration. All were radiology department technicians of the City Clinical Hospital applying diagnostic procedures. During the last fi ve years none exceeded the annual limit of 20 mSv. Six smoked, while the rest did not (see Table  1 ). The highest frequency of chromosomal aberrations was found in two nonsmokers and in one smoker. After the two-week treatment, tests have shown a significantly reduced frequency of chromosomal aberrations and micronuclei in nine of the 10 subjects, whereas leukocyte count decreased, but remained normal. The absolute granulocyte count dropped and monocyte count increased. The percentage of apoptotic cells also increased; it was 53.5 % (SD=25.26) before and 61.36 % (SD=23.36) after the treatment.
Furthermore, the two-week treatment with Echinacea purpurea restored a balance between haematological parameters. Echinacea owes its powerful radioprotective effects to the scavenging capacity of phenolic compounds caffeic acid, cichoric acid, and echinacoside. Earlier findings of the benefi cial effects of natural phenolic compounds have shown that they possess stronger antioxidant capacity than vitamins (13) . The radioprotective properties of medicinal plants such as Podophyllum hexandrum, Ocimum sanctum, Ginko biloba, and Mentha piperita have been attributed to the presence of polyphenols capable to stop propagation steps of lipid peroxidation and chelate transitional metal ions, and hence to inhibit free radical formation (14) .
Biologically active compounds of Echinacea reduce the yield of radiation-induced micronuclei, mainly by stimulating apoptosis, which is a radiorecovery effect. This effect is important, particularly for long-lived chromosomal aberrations, which could lead to the overexpression of oncogenes and to cancer development. Echinacea enhances apoptosis of irradiated cells as a physiological mechanism with no infl ammation, which looks promising for helping recovery after irradiation.
Adverse health effects of ionising radiation are still closely investigated. Radiation can activate oncogenes through a number of mechanisms including point mutation, chromosomal rearrangement, or chromosomal translocations. If irradiation results in the loss of a tumour suppressor gene, then it may become conducive to the expression of a malignant phenotype. Chromosomal aberrations in peripheral lymphocytes were found to be an intermediate endpoint in carcinogenesis (15, 16) . The study of Bonassi et al. (17) has also shown that a higher micronucleus frequency may also be related to overall genetic instability and is predictive of cancer proneness. Low doses of ionising radiation induce oxidative stress which can signifi cantly modulate some transcription factors. Once activated, these transcription factors might drive transcription of survival-related proteins. For instance, ionising radiation modulates more than 100 genes in human endothelial cells, causing up-regulation of genes involved in coagulation and peroxidase activity (18) . It also triggers signals that mobilise innate and adaptive immune systems to deal with the intrusion and repair tissue. Little is known about the role of signals in tissue responses to this agent. This signal could mediate the pathogenesis of or recovery from radiation damage and alter intrinsic cellular radiosensitivity (19) . A number of healthy individuals (10 % to 15 %) exhibit reduced (65 % to 80 % of normal) repair capacity phenotypes (20) . These damage-specific phenotypes are heritable traits associated with increased radiosensitivity. It is estimated that every individual will be a variant for 6 to 8 genes in both base excision repair and double-strand break repair pathways, whose primary responsibility is to repair DNA damage induced by ionising radiation (21) . One of the most important recently studied genes is the Nijmegen breakage syndrome (NBS1) gene. While NBS is a rare disease, it is estimated that a signifi cant proportion of the population may be heterozygous at this locus and be sensitive to radiation, even though they belong to "normal" population. NBS heterozygous individuals may be particularly susceptible to environmental, diagnostic, or therapeutic exposure to ionising radiation. Furthermore, heterozygous individuals may run an increased risk from ionising radiation at doses that are below the current workplace exposure limits.
Biologically active compounds from the Echinacea species are reported to possess immunomodulatory properties such as enhancement of monocytemacrophage activity (22) . In our study, monocyte count and apoptotic ability of leukocytes clearly increased, which is attributed to the Echinacea treatment.
Further investigation of common polymorphisms at relevant genes in humans would single out reagents for cellular biology experiments and molecular epidemiological studies employing a genotype-tophenotype/health consequence paradigm and refi ne risk estimates associated with exposure to low-level ionising radiation. Understanding radiation effects in terms of coordinated multicellular responses that affect cellular fate may necessitate re-evaluation of radiation dose and risk concepts and provide avenues for intervention.
CONCLUSION
Administration of Echinacea purpurea preparation significantly reduces the incidence of radiationinduced chromosomal aberrations and micronuclei in human lymphocytes of radiation workers. Its powerful radioprotective capacities are achieved through free radical scavenging performed by polyphenols, which stimulate apoptosis and enhance monocyte-macrophage activity. Echinacea purpurea posseses remarkable protective properties and its biological activity could be important for many other diseases where lipid peroxidation products have been reported.
